Antisense oligonucleotide to inhibit melanoma inhibitory...

Details Antisense oligonucleotide to inhibit melanoma inhibitory... Antisense oligonucleotide to inhibit melanoma inhibitory...

2011-03-22

2011-03-22

McGarry, Sean (Department: 1635)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C536S023100, C536S024300, C536S024330, C536S024500

Reexamination Certificate

active

07910563

ABSTRACT:
An antisense oligonucleotide selected from the group ofthe sequence 5′-TTG CAT AAA CCC AAG GAG-3′ (SEQ ID NO: 1) and modifications thereofa fragment having at least 8 nucleotides of the sequence 5′-TTG CAT AAA CCC AAG GAG-3′ (SEQ ID NO: 1) and modifications thereof.

REFERENCES:
patent: WO 99/50411 (1999-10-01), None
patent: WO 99/65928 (1999-12-01), None
patent: WO 01/68122 (2001-09-01), None
patent: WO 01/77384 (2001-10-01), None
patent: WO 2005/014812 (2005-02-01), None
Jachimczak et al. Inhibition of Immunosuppressive Effects of Melanoma-Inhibiting Activity (MIA) by Antisense Techniques. Int. J. Cancer, 2005 vol. 113:88-92.
EPO,European Search Report, EP Application No. 03018285.1-2107, dated Feb. 12, 2004.
Golob et al,Characterization of a Transcription Factor Binding Site, Specifically Activating MIA Transcription in Melanoma, J Invest Ermatol 115:42-47, 2000.
PCT,International Search Report, PCT Application No. PCT/EP2004/008986, mailed on Mar. 29, 2005.
Bogdahn, U. et al. / Autocrine Tumor Cell Growth-Inhibiting Activities . . . / Cancer Research, 1989. 49 (19): 5358-5363.
Weilbach, F.X. et al. / Melanoma-Inhibiting Activity Inhibits Cell . . . Cancer Research, 1990. 50 (21): 6981-6986.
Blesch, A. et al. / Cloning of a Novel Malignant Melanoma-Derived Growth-Regulatory Protein, MIA. / Cancer Research, 1994. 54(21): 5695-5701.
van Groningen, JJ, et al. / Identification of Melanoma Inhibitory Activity and Other Differentially Expressed . . . / Cancer Research, 1995. 55(24): 6237-6243.
Bosserhoff, AK et al. / [MIA (“melanoma inhibitory activity”). Biological functions and clinical relevance in malignant melanoma]. Hautarzt, 1998. 49(10): 762-769.
Guba, M. et al. / Overexpression of Melanoma Inhibitory Activity (MIA) Enhances . . . / Br J Cancer, 2000. 83(9): 1216-1222.
Bosserhoff, AK et al. / Functional Role of Melanoma Inhibitory Activity in Regulating Invasion and Metastasis of Malignant Melanoma Cells in Vivo. / Melanoma Res, 2001. 11(4): 417-421.
Stahlecker, J. et al. / MIA as a Reliable Tumor Marker in the Serum of Patients with Malignant Melanoma / Anticancer Res, 2000 20(6D): 5041-5044.
Uhlmann, E. et al. / Antisense Oligonucleotides: A New Therapeutic Principle., Chemical Reviews, 1990. 90(4): 543-584.
Goodchild, J. / Conjugates of oligonucleotides and modified oligonucleotides: a review of their synthesis and properties. Bioconjug Chem, 1990. 1(3): 165-187.
Wagner, V. et al. / Seropositivity for MIA and S100 in Patients with Gastrointestinal Carcinomas. / Med Oncol, 2000. 17(1): 35-38.
Natsume, N. et al. Analysis of Cartilage-Derived Retinoic Acid-Sensitive Protein . . . / Spine, 2001. 26(2): 157-160.
Bosserhoff, AK et al. / Mouse CD-RAP/MIA Gene: Structure, Chromosomal Localization, and Expression . . . / Dev Dyn, 1997. 208(4): 516-525.
Muller-Ladner, U et al. / MIA (melanoma inhibitory activity): a potential serum marker for rheumatoid arthritis, / Rheumatology (Oxford), 1999. 38(2): 148-154.
Bosserhoff, AK et al. / In Situ Expression Patterns of Melanoma-Inhibiting Activity . . . J Pathology, 1999. 187(4): 446-454.
Zhao, Q et al. / Site of Chemical Modifications in CpG Containing Phosphorothioate . . . Bioorg Medical Chem Lett, 1999. 9(24): 3453-3458.
Scaringe, SA / RNA Oligonucleotide Synthesis via 5′-silyl-2-orthoester chemistry / Methods, 2001. 23(3): 206-217.
Flaherty, KT et al. / Antisense Therapeutics: Lessons from early clinical Trials . . . Curr Opin Oncol, 2001. 13(6): 499-505.

Affiliated with

Also associated with

Rating

Antisense oligonucleotide to inhibit melanoma inhibitory... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antisense oligonucleotide to inhibit melanoma inhibitory..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense oligonucleotide to inhibit melanoma inhibitory... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2668657